Nutex Health, Inc. reported significant financial growth for the fiscal year ending December 31, 2025, with total revenue reaching $875.3 million, a substantial increase of 83% from $480.0 million in 2024. The hospital division was the primary driver of this growth, generating $844.2 million in revenue, up 88% from the previous year. The population health management division also saw a slight increase in revenue, totaling $31.1 million compared to $30.9 million in 2024. The company achieved a net income of $70.8 million, or $10.48 per share, compared to a net income of $52.1 million, or $9.69 per share, in the prior year.

The company's operational metrics reflected a positive trend, with patient visits increasing by 11.8% year-over-year, attributed to the opening of two new hospital facilities and a rise in revenue per visit due to successful negotiations through the Independent Dispute Resolution (IDR) process. Nutex Health's total employee count stood at 944, with over 3,600 physicians and specialists partnered within its networks. The company also expanded its footprint, operating 26 hospital facilities across 12 states, with plans to open four additional facilities in 2026.

Strategically, Nutex Health engaged HaloMD, a third-party vendor, to assist with out-of-network claims and arbitration processes, which has contributed to improved revenue collection. The company also made significant investments in stock-based compensation, totaling $117.0 million for 2025, reflecting obligations related to under-construction and ramping hospitals. This was a notable increase from $16.6 million in 2024, impacting the overall corporate costs, which rose to $168.7 million from $65.6 million in the previous year.

Looking ahead, Nutex Health aims to continue its growth trajectory by expanding its clinical services and establishing new independent physician associations (IPAs) in markets where it operates micro-hospitals. The company anticipates launching one to three additional IPAs annually, leveraging its existing physician relationships. However, the company acknowledged potential risks, including regulatory changes and market competition, which could impact its ability to maintain growth and profitability. Nutex Health's management remains focused on enhancing operational efficiencies and navigating the complexities of the healthcare landscape to sustain its upward momentum.

About Nutex Health, Inc.

Nutex Health Inc. operates a healthcare services platform with 24 micro-hospitals and physician networks across the U.S. Its core activities include developing innovative outpatient facilities, managing population health through IPAs, and providing comprehensive, patient-centric care. The company leverages physician partnerships, scalable models, and community-focused strategies to deliver high-quality emergency and primary care in high-demand markets.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-K Filings

A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.

Key points about the 10-K:

  • Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
  • Content: It includes:
    • Detailed financial statements audited by an independent accounting firm
    • Management's Discussion and Analysis (MD&A) of financial condition and results
    • Description of the company's business, properties, and legal proceedings
    • Risk factors and market risks
    • Executive compensation and corporate governance information
  • Importance: Considered the most comprehensive and important document a public company files with the SEC.
  • Length: Often exceeds 100 pages due to its extensive and detailed nature.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.